» Articles » PMID: 8791135

Tumoral Vascularity As a Prognostic Factor in Cancer

Overview
Specialty Oncology
Date 1996 Jan 1
PMID 8791135
Citations 37
Authors
Affiliations
Soon will be listed here.
Citing Articles

Poisson Statistical Model of Ultrasound Super-Resolution Imaging Acquisition Time.

Christensen-Jeffries K, Brown J, Harput S, Zhang G, Zhu J, Tang M IEEE Trans Ultrason Ferroelectr Freq Control. 2019; 66(7):1246-1254.

PMID: 31107645 PMC: 7614131. DOI: 10.1109/TUFFC.2019.2916603.


Early Actions of Anti-Vascular Endothelial Growth Factor/Vascular Endothelial Growth Factor Receptor Drugs on Angiogenic Blood Vessels.

Sitohy B, Chang S, Sciuto T, Masse E, Shen M, Kang P Am J Pathol. 2017; 187(10):2337-2347.

PMID: 28736316 PMC: 5809587. DOI: 10.1016/j.ajpath.2017.06.010.


N-acetylglucosaminyl 1-phosphate transferase: an excellent target for developing new generation breast cancer therapeutic.

Banerjee A, Martinez J, Longas M, Zhang Z, Santiago J, Baksi K Adv Exp Med Biol. 2014; 842:355-74.

PMID: 25408354 PMC: 4603827. DOI: 10.1007/978-3-319-11280-0_22.


A phase II evaluation of nintedanib (BIBF-1120) in the treatment of recurrent or persistent endometrial cancer: an NRG Oncology/Gynecologic Oncology Group Study.

Dizon D, Sill M, Schilder J, McGonigle K, Rahman Z, Miller D Gynecol Oncol. 2014; 135(3):441-5.

PMID: 25312396 PMC: 4373614. DOI: 10.1016/j.ygyno.2014.10.001.


Metabotropic glutamate receptor-1 as a novel target for the antiangiogenic treatment of breast cancer.

Speyer C, Hachem A, Assi A, Johnson J, deVries J, Gorski D PLoS One. 2014; 9(3):e88830.

PMID: 24633367 PMC: 3954556. DOI: 10.1371/journal.pone.0088830.